Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Hypertension

ACE inhibitor use in pregnancy—setting the record straight

A study by Li and coworkers demonstrates that antihypertensive-drug use and untreated hypertension in pregnancy increase the risk of congenital malformations. Supported by the results of meta-analysis, this study heralds a major shift in our understanding of the fetal risks of hypertension and the medications used to treat this condition.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Li, D. K., Yang, C., Andrade, S., Tavares, V. & Ferber, J. R. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 343, d5931 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Koren, G., Pastuszak, A. & Ito, S. Drugs in pregnancy. N. Engl. J. Med. 338, 1128–1137 (1998).

    Article  CAS  PubMed  Google Scholar 

  3. Ratnapalan, S. & Koren, G. Taking ACE inhibitors during pregnancy. Is it safe? Can. Fam. Physician 48, 1047–1049 (2002).

    PubMed  PubMed Central  Google Scholar 

  4. Cooper, W. O. et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N. Engl. J. Med. 354, 2443–2451 (2006).

    Article  CAS  PubMed  Google Scholar 

  5. Muntner, P. et al. Low medication adherence and the incidence of stroke symptoms among individuals with hypertension: the REGARDS study. J. Clin. Hypertens. (Greenwich) 13, 479–486 (2011).

    Article  Google Scholar 

  6. Källén, B., Nilsson, E. & Olausson, P. O. Antidepressant use during pregnancy: comparison of data obtained from a prescription register and from antenatal care records. Eur. J. Clin. Pharmacol. 67, 839–845 (2011).

    Article  PubMed  Google Scholar 

  7. Walfisch, A., Al-maawali, A., Moretti, M. E., Nickel, C. & Koren, G. Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers. J. Obstet. Gynaecol. 31, 465–472 (2011).

    Article  CAS  PubMed  Google Scholar 

  8. Chen, C. H. & Lin, H. C. Prenatal care and adverse pregnancy outcomes among women with depression: a nationwide population-based study. Can. J. Psychiatry 56, 273–280 (2011).

    Article  PubMed  Google Scholar 

  9. Eltonsy, S., Forget, A. & Blais, L. Beta2-agonists use during pregnancy and the risk of congenital malformation. Birth Defects Res. A Clin. Mol. Teratol. 91, 937–947 (2011).

    Article  CAS  PubMed  Google Scholar 

  10. Chang, S. D. et al. Analyses of placental gene expression in pregnancy-related hypertensive disorders. Taiwan J. Obstet. Gynecol. 50, 283–291 (2011).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koren, G. ACE inhibitor use in pregnancy—setting the record straight. Nat Rev Cardiol 9, 7–8 (2012). https://doi.org/10.1038/nrcardio.2011.179

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2011.179

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing